Portal Biotech

Overview

London-based biotech founded by Andrew Heron, applying Oxford Nanopore sequencing lessons to develop accessible molecular biosensing tools for biopharma and bioprocessing. Portal Biotech is building accessible, scalable, cost-effective molecular biosensing technologies for biopharma and bioprocessing, leveraging lessons from the commercialization of Oxford Nanopore NGS in regulated sectors. Portal Biotech is developing Raman spectroscopy and other real-time analytical methods to extract molecular insight about how bioprocessing conditions affect product outcomes, aiming to bring these into live process environments. (Segment 1 (00:00-05:00))